Long-term, low-dose azithromycin is effective but underused in patients with persistent asthma and other obstructive airway disease (OAD), according to findings from a study of real-world prescribing patterns of the macrolide in Australia. Investigators from Hunter Medical Research Institute (HMRI) in NSW who carried out the evaluation said most patients responded positively to the treatment, ...
How is long-term azithromycin being used by respiratory physicians in Australia?
By Sunalie Silva
15 Feb 2021